Christoph Lam
Child & Adolescent Psychiatry · Philadelphia, PANPI 1750461976
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $12,945 with a category attached, or 77.3%. Boston Scientific accounts for 77.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $10,792 and has fallen 95.7% since, to $460 in 2025. Among child & adolescent psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $126.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Supernus Pharmaceuticals, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$399
- Corium, LLC$380
- Takeda Pharmaceuticals U.S.A., Inc.$248
- Bausch Health US, LLC$146
- plus $635 from 11 others
What the payments were for
- Speaking & faculty fees$1,0008%
- Grants$10,00077%
- Food & beverage$1,93815%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 1 | $10,000 |
| Supernus Pharmaceuticals, Inc. | 8 | $1,137 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $399 |
| Corium, LLC | 18 | $380 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $248 |
| Bausch Health US, LLC | 10 | $146 |
| Sunovion Pharmaceuticals Inc. | 2 | $131 |
| Rhodes Pharmaceuticals L.p. | 8 | $113 |
| Tris Pharma Inc | 8 | $109 |
| Adlon Therapeutics L.p. | 5 | $72 |
| Shire North American Group Inc | 5 | $69 |
| Ironshore Pharmaceuticals Inc. | 3 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Neos Therapeutics, LP | 2 | $27 |
| AbbVie | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAIN MANAGEMENT$10,000
- CAPLYTA$246
- Azstarys$125
- LATUDA$125
How this compares
$12,945 in reported general payments places this provider in the 95th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.
See all child & adolescent psychiatry providers in Pennsylvania →
Other child & adolescent psychiatry in Philadelphia
- Thomas WindPhiladelphia$17K
- Laura AdangPhiladelphia$15K
- Mahendra PatilPhiladelphia$7K
- David LopezPhiladelphia$3K
- Pamela RalphPhiladelphia$3K
- Fathima MusthaqPhiladelphia$2K
- Michael InestaPhiladelphia$1K
- Stacy McAllisterPhiladelphia$1K
- Alejandra WortmanPhiladelphia$812
- Dennis BorczonErie$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.